NICE guidance (NG28) recommends: HbA1c monitoring every 36 months until stable, then 6-monthly Renal function tests at least annually (more frequently if pre-existing kidney disease) Weight and BMI tracking to assess treatment response Blood pressure monitoring , as weight loss may allow reduction in antihypertensive medications Appropriate retinopathy screening for patients with diabetes, particularly those with pre-existing retinopathy taking semaglutide Communication with your healthcare team is vital
Nguyen TL, Vieira-Silva S, Liston A, Raes J
Metabolaid supports weight management, healthy cholesterol levels, blood pressure, gut microbiota health and satiety through gut hormone regulation
Significara que la obesidad es an ms peligrosa de lo que ya se cree
Additionally, longitudinal studies are crucial for evaluating the efficacy and safety of these treatments, particularly in vulnerable populations, such as adolescents and individuals with pre-existing conditions
